Disaggregated Revenues (Tables)

3 Months Ended

Mar. 31, 2022

Disaggregation of Revenue [Abstract]

Summary of disaggregation of revenues by nature

The following table summarizes the disaggregation of revenues by product or source, (dollars in thousands):

	Three Months ended March 31,
	2022		2021
	(unaudited)
Net product sales
Trokendi XR	$	62,832	$	71,819
Oxtellar XR	27,521		27,370
GOCOVRI	22,601		—
APOKYN	18,448		21,730
Qelbree	8,283		—
Other(1)	7,779		7,462
Total net product sales	$	147,464	$	128,381
Royalty revenues	5,042		2,551
Total revenues	$	152,506	$	130,932

___________________________________________

(1) Includes net product sales of MYOBLOC, XADAGO and OSMOLEX ER.